ES2157686T3 - Nanoemulsion a base de citratos de alquileter y sus utilizaciones en los ambitos cosmetico, dermatologico, farmaceutico y/o oftalmico. - Google Patents

Nanoemulsion a base de citratos de alquileter y sus utilizaciones en los ambitos cosmetico, dermatologico, farmaceutico y/o oftalmico.

Info

Publication number
ES2157686T3
ES2157686T3 ES99402914T ES99402914T ES2157686T3 ES 2157686 T3 ES2157686 T3 ES 2157686T3 ES 99402914 T ES99402914 T ES 99402914T ES 99402914 T ES99402914 T ES 99402914T ES 2157686 T3 ES2157686 T3 ES 2157686T3
Authority
ES
Spain
Prior art keywords
ophthalm
dermatological
citrates
rental
cosmetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99402914T
Other languages
English (en)
Inventor
Jean-Tierry Simonnet
Sylvie Legret
Odile Sonneville
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Application granted granted Critical
Publication of ES2157686T3 publication Critical patent/ES2157686T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A61K8/062—Oil-in-water emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/14—Preparations for removing make-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/21—Emulsions characterized by droplet sizes below 1 micron
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/413—Nanosized, i.e. having sizes below 100 nm

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Toxicology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Una nanoemulsión que comprende una fase aceitosa dispersada en una fase acuosa y que tiene glóbulos de aceite, cuyo tamaño medio en número es inferior a 100 nm, caracterizada porque contiene al menos un tensioactivo aniónico elegido entre los citratos de alquiléter, en cantidad que va de 0,2 a 15 % en peso con respecto al peso total de la nanoemulsión, y al menos un aceite que tiene un peso molecular superior a 400, y porque la relación en peso de la cantidad de fase aceitosa sobre la cantidad de tensioactivo va de 2 a 10.
ES99402914T 1999-01-14 1999-11-23 Nanoemulsion a base de citratos de alquileter y sus utilizaciones en los ambitos cosmetico, dermatologico, farmaceutico y/o oftalmico. Expired - Lifetime ES2157686T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9900408A FR2788449B1 (fr) 1999-01-14 1999-01-14 Nanoemulsion a base de citrates d'alkylether, et ses utilisations dans les domaines cosmetique, dermatologique, pharmaceutique et/ou ophtalmologique

Publications (1)

Publication Number Publication Date
ES2157686T3 true ES2157686T3 (es) 2001-08-16

Family

ID=9540905

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99402914T Expired - Lifetime ES2157686T3 (es) 1999-01-14 1999-11-23 Nanoemulsion a base de citratos de alquileter y sus utilizaciones en los ambitos cosmetico, dermatologico, farmaceutico y/o oftalmico.

Country Status (8)

Country Link
US (1) US6413527B1 (es)
EP (1) EP1020219B1 (es)
JP (1) JP3545299B2 (es)
KR (1) KR100369260B1 (es)
AT (1) ATE199841T1 (es)
DE (1) DE69900066T2 (es)
ES (1) ES2157686T3 (es)
FR (1) FR2788449B1 (es)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1105096B1 (en) 1998-08-19 2003-10-29 Skyepharma Canada Inc. Injectable aqueous dispersions of propofol
US8263580B2 (en) 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
FR2787027B1 (fr) * 1998-12-14 2001-01-12 Oreal Nanoemulsion a base d'esters gras de sucre ou d'ethers gras de sucre et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
US6821509B2 (en) 2000-04-14 2004-11-23 Cosmetica, Inc. Nanoscopic hair care products
FR2811564B1 (fr) * 2000-07-13 2002-12-27 Oreal Nanoemulsion contenant des polymeres non ioniques, et ses utilisations notamment dans les domaines cosmetique, dermatologique, pharmaceutique et/ou ophtalmologique
EP1903056A3 (en) 2002-12-10 2008-05-07 Idm Pharma, Inc. HLA-A1, -A2 -A3, -A24, -B7, and -B44 binding peptides comprising tumor associated antigen epitopes, and compositions thereof
AU2004232971A1 (en) 2003-04-18 2004-11-04 Idm Pharma Inc. HLA-A2 tumor associated antigen peptides and compositions
DE10319399A1 (de) * 2003-04-30 2004-11-18 Cognis Deutschland Gmbh & Co. Kg Kosmetische und/oder pharmazeutische Zubereitungen
DE10319401A1 (de) * 2003-04-30 2004-11-18 Cognis Deutschland Gmbh & Co. Kg Citronensäureester
DE10319400A1 (de) * 2003-04-30 2004-11-18 Cognis Deutschland Gmbh & Co. Kg Verwendung von Hydroxycarbonsäureestern
US8449867B2 (en) 2004-08-31 2013-05-28 Stiefel Research Australia Pty Ltd Microemulsion and sub-micron emulsion process and compositions
CA2756674C (en) * 2004-08-31 2012-04-03 Stiefel Research Australia Pty Ltd Microemulsion & sub-micron emulsion process & compositions
EP1796636B2 (en) 2004-08-31 2016-12-14 Stiefel Research Australia Pty Ltd Microemulsion & sub-micron emulsion process & compositions
DE102004054036A1 (de) * 2004-11-05 2006-05-11 Cognis Ip Management Gmbh Verwendung von alkoxylierten Hydroxycarbonsäureestern zur Lösungsvermittlung von Parfümölen in Wasser
DE102004054842A1 (de) * 2004-11-12 2006-05-24 Cognis Ip Management Gmbh Ölhaltige Tensidgele
US20060204469A1 (en) * 2005-03-09 2006-09-14 Eric Spengler Stable mixed emulsions
US20060263438A1 (en) * 2005-05-17 2006-11-23 L'oreal Gelled oil particles for targeting sebaceous glands and/or hair follicles
FR2885797B1 (fr) * 2005-05-17 2007-07-27 Oreal Particules d'huile gelifiee comportant au moins un filtre solaire hydrophobe
TWI402034B (zh) * 2005-07-28 2013-07-21 Dow Agrosciences Llc 具有被層狀液晶覆膜包覆之油球之水包油乳化劑之農用組成物
US20070108418A1 (en) * 2005-08-09 2007-05-17 Soane Laboratories, Llc Hair hold formulations
US20070065390A1 (en) * 2005-09-19 2007-03-22 Eric Spengler Stable emulsion systems with high salt tolerance
EP1938801A1 (en) * 2006-12-22 2008-07-02 Biofrontera Bioscience GmbH Nanoemulsion
BRPI0907480B1 (pt) * 2008-02-04 2019-09-03 Dow Agrosciences Llc Composições de emulsões de óleo em água estabilizadas incluindo ingredientes agricolamente ativos, e métodos para controlar ou prevenir ataque fúngico, inibirinsetos, prevenir ou controlar vegetação indesejável, prevenir ou controlar nematódeos, prevenir ou controlar ácaros, prevenir ou controlar artrópodes,prevenir ou controlar bactérias e outros micro-organismos, prevenir ou controlar roedores, e para prevenir ou controlar cupins
WO2009145959A1 (en) * 2008-03-07 2009-12-03 University Of Toledo High throughput carbon nanotube growth system, and carbon nanotubes and carbon nanofibers formed thereby
SI2273872T1 (sl) * 2008-03-07 2016-02-29 Dow Agrosciences Llc Stabilizirane emulzije olja v vodi, ki vključujejo agrikulturno aktivne sestavine
DK2271212T3 (en) * 2008-03-07 2017-12-04 Dow Agrosciences Llc STABILIZED OIL-IN-WATER EMULSIONS CONTAINING AGRICULTURALLY ACTIVE INGREDIENTS
FR2938191B1 (fr) 2008-11-07 2011-01-14 Oreal Emulsion huile-dans-eau contenant un polymere amphiphile et un elastomere silicone
CA2751612A1 (en) 2009-02-06 2010-08-12 The Regents Of The University Of California Calcium-binding agents induce hair growth and/or nail growth
US20110229516A1 (en) * 2010-03-18 2011-09-22 The Clorox Company Adjuvant phase inversion concentrated nanoemulsion compositions
DE102010021688A1 (de) 2010-05-27 2011-12-01 Qineva Gmbh & Co. Kg Verfahren zur Herstellung eines micellaren Wirkstoffkonzentrats
DE102010056192A1 (de) 2010-12-28 2012-06-28 Gabriele Blume Kolloidales Trägersystem mit penetrierenden Eigenschaften zum Einschließen lipophiler Wirkstoffe und Öle für die topische Anwendung
CN103442558B (zh) 2011-01-14 2015-04-08 陶氏益农公司 包含水包油乳剂的农业组合物
CA2867891C (en) 2012-03-19 2021-09-14 Buck Institute For Research On Aging App specific bace inhibitors (asbis) and uses thereof
FR2998793B1 (fr) 2012-11-30 2014-11-28 Oreal Composition cosmetique sous forme d'emulsion huile-dans-eau
US10202355B2 (en) 2013-02-12 2019-02-12 Buck Institute For Research On Aging Hydantoins that modulate bace-mediated app processing
CA3049212A1 (en) 2017-01-05 2018-07-12 The Regents Of The University Of California Pac1 receptor agonists (maxcaps) and uses thereof
GB2584009B (en) 2017-08-28 2022-03-23 Revagenix Inc Aminoglycosides and uses thereof
KR102692643B1 (ko) 2017-11-10 2024-08-06 (주)아모레퍼시픽 바이겔 타입의 화장료 조성물
WO2019194858A1 (en) 2018-04-03 2019-10-10 Achaogen, Inc. Modular synthesis of aminoglycosides
US20200147032A1 (en) 2018-11-14 2020-05-14 Robert K. Prud'homme Dihydromyricetin hot melt extrusion formulations and methods for forming them
KR102643707B1 (ko) 2019-01-22 2024-03-04 에오비안 파마슈티컬스, 인크. Mtorc 조절제 및 이의 용도
CA3245419A1 (en) 2022-03-04 2023-09-07 Revagenix, Inc. Broad-spectrum aminoglycosides and their uses
WO2024208433A1 (en) 2023-04-06 2024-10-10 Biofrontera Bioscience Gmbh Nanoemulsion without propylene glycol
WO2024208434A1 (en) 2023-04-06 2024-10-10 Biofrontera Bioscience Gmbh Pressurized nanoemulsion
WO2025046492A1 (en) 2023-08-31 2025-03-06 Revagenix, Inc. Broad spectrum aminoglycosides and uses thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4797272A (en) * 1985-11-15 1989-01-10 Eli Lilly And Company Water-in-oil microemulsions for cosmetic uses
FR2694494B1 (fr) * 1992-08-05 1994-09-30 Rhone Poulenc Chimie Composition cosmétique contenant en suspension des particules non hydrosolubles.
US5716418A (en) * 1992-08-22 1998-02-10 Henkel Kommanditgesellschaft Auf Aktien Coloring of keratin-containing fibers with preparations which contain alkyl glycosides and oxidation dye precursors
US5576279A (en) * 1993-05-17 1996-11-19 Helene Curtis, Inc. Stable conditioning shampoo containing an anionic surfactant a fatty alcohol, and polyethyleneimine
US5523025A (en) * 1995-02-23 1996-06-04 Colgate-Palmolive Co Microemulsion light duty liquid cleaning compositions
FR2742676B1 (fr) * 1995-12-21 1998-02-06 Oreal Nanoemulsion transparente a base de tensioactifs silicones et utilisation en cosmetique ou en dermopharmacie
FR2742677B1 (fr) * 1995-12-21 1998-01-16 Oreal Nanoparticules enrobees d'une phase lamellaire a base de tensioactif silicone et compositions les contenant
US5871762A (en) * 1996-10-07 1999-02-16 The Procter & Gamble Company Cosmetic applicators which contain stable oil-in-water emulsions
FR2755854B1 (fr) * 1996-11-15 1998-12-24 Oreal Nanoemulsion a base de lipides amphiphiles non-ioniques et cationiques et utilisations
EP0852941B1 (de) * 1996-12-13 2003-05-14 Vesifact Ag Kosmetische Präparate in Form einer Nanodispersion
FR2760970B1 (fr) * 1997-03-18 2000-03-10 Oreal Nanoemulsions a base de lipides amphiphiles non-ioniques et de silicones aminees et utilisations
FR2763853B1 (fr) * 1997-05-28 2000-01-07 Oreal Association d'un retinoide avec un polymere polyamine

Also Published As

Publication number Publication date
ATE199841T1 (de) 2001-04-15
US6413527B1 (en) 2002-07-02
DE69900066T2 (de) 2001-07-19
FR2788449B1 (fr) 2001-02-16
FR2788449A1 (fr) 2000-07-21
EP1020219B1 (fr) 2001-03-21
KR20000052504A (ko) 2000-08-25
KR100369260B1 (ko) 2003-01-24
JP2000212030A (ja) 2000-08-02
DE69900066D1 (de) 2001-04-26
EP1020219A1 (fr) 2000-07-19
JP3545299B2 (ja) 2004-07-21

Similar Documents

Publication Publication Date Title
ES2157686T3 (es) Nanoemulsion a base de citratos de alquileter y sus utilizaciones en los ambitos cosmetico, dermatologico, farmaceutico y/o oftalmico.
FR2787703B1 (fr) Nanoemulsion a base d'ethers gras ethoxyles ou d'esters gras ethoxyles, et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
DE602004004013D1 (de) Schaumerzeugender kit enthaltend einen schaumspender und eine zusammensetzung mit hohem tensidanteil
FR2787326B1 (fr) Nanoemulsion a base d'esters gras de glycerol, et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
ATE206632T1 (de) Nanoemulsion aus fettsäureestern von phosphorsäure und deren verwendung in kosmetika, dermatologie, pharmazeutika und/oder ophthalmologie
FR2788007B1 (fr) Nanoemulsion a base de copolymeres blocs d'oxyde d'ethylene et d'oxyde de propylene, et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
BR9907330A (pt) Nanoemulsão, composição para uso tópico, suporte oftálmico, utilização cosmética da nanoemulsão, processo cosmético de cuidado e/ou hidratação, utilização da nanoemulsão e processo de preparação de uma nanoemulsão
AU2001279631A1 (en) Self-emulsifying active substance formulation and use of this formulation
EP1387614A4 (en) PROCESS FOR THE PREPARATION OF A PURIFIED COMPOSITION OF SHILAJIT FROM NATIVE SHILAJIT
DE69720535D1 (de) Die wirkstoffresistenz in der krebs-chemotherapie umkehrende taxoide mittel und pharmazeutische zubereitungen davon
FR2787026B1 (fr) Nanoemulsion a base d'esters mixtes d'acide gras ou d'alcool gras, d'acide carboxylique et de glyceryle, et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
NO20025629D0 (no) Formulering
BRPI9902068B8 (pt) nanodispersão, seu uso e sua pré-fase, e formulação farmacêutica líquida, semi-sólida ou sólida.
KR950007855A (ko) 정맥내 주사용 라파마이신 제형
ATE230612T1 (de) Stabile pulverförmige vitamin- und carotinoid- zubereitungen und vefahren zu deren herstellung
ES2122243T3 (es) Mejoras para limpiadores de superficies duras.
ATE269047T1 (de) Emulgatorfreie und bornitrid enthaltende feindisperse systeme vom typ öl-in-wasser und wasser-in-öl
ATE159250T1 (de) Neue pyrazinderivative, ihre herstellung und verwendung
KR910002449A (ko) 국소 스피로노락톤 조성물
PT1249230E (pt) Pre-concentrados de microemulsao e microemulsoes que contem coenzima q10 sua preparacao e utilizacao
CO4930324A1 (es) Composicion quimica que contiene un sistema preservativo y metodo para elaborar y usar tal composicion
FI910112A0 (fi) Preparat foer lokalt bruk.
CA2200598A1 (en) Novel Anti-Oxidative, Tricyclic, Condensed Heterocyclic Compound
BR7800795U (pt) Disposição em flange de base de assento.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 1020219

Country of ref document: ES